Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent cliff
Pharma
Merck touts newly approved Winrevair as example of BD acumen
Merck touted newly approved Winrevair and what the emergence of the potential blockbuster means for the company as it faces the Keytruda LOE.
Kevin Dunleavy
Apr 25, 2024 11:06am
Bayer CEO tables split-up, begins 'full-scale effort' for pharma
Mar 5, 2024 10:17am
BMS CEO outlines transition strategy featuring 11 brands, BD
Feb 2, 2024 11:30am
Patent cliffs and divestitures point to an uptick in M&A
Sep 7, 2023 3:22pm
Amid shortage, FDA clears several generics of Takeda's Vyvanse
Aug 30, 2023 2:27pm
Takeda, AstraZeneca, Astellas and more—Fierce Pharma Asia
May 19, 2023 9:25am
